24-Apr-2024
No headlines found.
PRNewswire (Sat, 6-Apr 12:56 AM ET)
Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2024 Financial Results
PRNewswire (Wed, 3-Apr 7:30 AM ET)
PRNewswire (Thu, 22-Feb 7:30 AM ET)
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2024
PRNewswire (Wed, 21-Feb 7:00 AM ET)
PRNewswire (Mon, 12-Feb 7:30 AM ET)
PRNewswire (Mon, 12-Feb 7:00 AM ET)
Zimmer Biomet Announces Fourth Quarter and Full-Year 2023 Financial Results
PRNewswire (Thu, 8-Feb 6:30 AM ET)
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Zimmer Biomet Holdings trades on the NYSE stock market under the symbol ZBH.
As of April 24, 2024, ZBH stock price declined to $121.17 with 829,288 million shares trading.
ZBH has a beta of 1.07, meaning it tends to be more sensitive to market movements. ZBH has a correlation of 0.30 to the broad based SPY ETF.
ZBH has a market cap of $24.90 billion. This is considered a Large Cap stock.
Last quarter Zimmer Biomet Holdings reported $2 billion in Revenue and $2.20 earnings per share. This beat revenue expectation by $10 million and exceeded earnings estimates by $.05.
In the last 3 years, ZBH stock traded as high as $180.36 and as low as $100.39.
The top ETF exchange traded funds that ZBH belongs to (by Net Assets): VTI, VOO, VO, MOAT, SPY.
ZBH has underperformed the market in the last year with a price return of -11.6% while the SPY ETF gained +24.1%. ZBH has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +0.7% and -5.1%, respectively, while the SPY returned +4.5% and -1.7%, respectively.
ZBH support price is $119.74 and resistance is $123.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ZBH stock will trade within this expected range on the day.